120 related articles for article (PubMed ID: 36824757)
1. Cell aggregation prevents anoikis and induces CD44 cleavage by maintaining lipid raft integrity to promote triple negative breast cancer metastasis.
Li D; Park Y; Hemati H; Liu X
Res Sq; 2023 Feb; ():. PubMed ID: 36824757
[TBL] [Abstract][Full Text] [Related]
2. Cell aggregation activates small GTPase Rac1 and induces CD44 cleavage by maintaining lipid raft integrity.
Li D; Park Y; Hemati H; Liu X
J Biol Chem; 2023 Dec; 299(12):105377. PubMed ID: 37866630
[TBL] [Abstract][Full Text] [Related]
3. Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models.
Liu X; Taftaf R; Kawaguchi M; Chang YF; Chen W; Entenberg D; Zhang Y; Gerratana L; Huang S; Patel DB; Tsui E; Adorno-Cruz V; Chirieleison SM; Cao Y; Harney AS; Patel S; Patsialou A; Shen Y; Avril S; Gilmore HL; Lathia JD; Abbott DW; Cristofanilli M; Condeelis JS; Liu H
Cancer Discov; 2019 Jan; 9(1):96-113. PubMed ID: 30361447
[TBL] [Abstract][Full Text] [Related]
4. EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer.
Liu X; Adorno-Cruz V; Chang YF; Jia Y; Kawaguchi M; Dashzeveg NK; Taftaf R; Ramos EK; Schuster EJ; El-Shennawy L; Patel D; Zhang Y; Cristofanilli M; Liu H
Theranostics; 2021; 11(13):6632-6643. PubMed ID: 33995681
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Domains I and II of cell-surface glycoprotein CD44 mediate its
Kawaguchi M; Dashzeveg N; Cao Y; Jia Y; Liu X; Shen Y; Liu H
J Biol Chem; 2020 Feb; 295(9):2640-2649. PubMed ID: 31969394
[TBL] [Abstract][Full Text] [Related]
6. Lipid raft association restricts CD44-ezrin interaction and promotion of breast cancer cell migration.
Donatello S; Babina IS; Hazelwood LD; Hill AD; Nabi IR; Hopkins AM
Am J Pathol; 2012 Dec; 181(6):2172-87. PubMed ID: 23031255
[TBL] [Abstract][Full Text] [Related]
7. A novel mechanism of regulating breast cancer cell migration via palmitoylation-dependent alterations in the lipid raft affiliation of CD44.
Babina IS; McSherry EA; Donatello S; Hill AD; Hopkins AM
Breast Cancer Res; 2014 Feb; 16(1):R19. PubMed ID: 24512624
[TBL] [Abstract][Full Text] [Related]
8. Machine learning-assisted elucidation of CD81-CD44 interactions in promoting cancer stemness and extracellular vesicle integrity.
Ramos EK; Tsai CF; Jia Y; Cao Y; Manu M; Taftaf R; Hoffmann AD; El-Shennawy L; Gritsenko MA; Adorno-Cruz V; Schuster EJ; Scholten D; Patel D; Liu X; Patel P; Wray B; Zhang Y; Zhang S; Moore RJ; Mathews JV; Schipma MJ; Liu T; Tokars VL; Cristofanilli M; Shi T; Shen Y; Dashzeveg NK; Liu H
Elife; 2022 Oct; 11():. PubMed ID: 36193887
[TBL] [Abstract][Full Text] [Related]
9. ICAM-1-suPAR-CD11b Axis Is a Novel Therapeutic Target for Metastatic Triple-Negative Breast Cancer.
Li D; Hemati H; Park Y; Taftaf R; Zhang Y; Liu J; Cristofanilli M; Liu X
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345070
[TBL] [Abstract][Full Text] [Related]
10. CD44 engagement promotes matrix-derived survival through the CD44-SRC-integrin axis in lipid rafts.
Lee JL; Wang MJ; Sudhir PR; Chen JY
Mol Cell Biol; 2008 Sep; 28(18):5710-23. PubMed ID: 18644869
[TBL] [Abstract][Full Text] [Related]
11. OSM-induced CD44 contributes to breast cancer metastatic potential through cell detachment but not epithelial-mesenchymal transition.
Covert H; Mellor LF; Wolf CL; Ankenbrandt N; Emathinger JM; Tawara K; Oxford JT; Jorcyk CL
Cancer Manag Res; 2019; 11():7721-7737. PubMed ID: 31496817
[TBL] [Abstract][Full Text] [Related]
12. An indispensable role of TAZ in anoikis resistance promoted by OTUB1 deubiquitinating enzyme in basal-like triple-negative breast cancer cells.
Nakagawa H; Higurashi M; Ishikawa F; Mori K; Shibanuma M
Biochem Biophys Res Commun; 2023 Mar; 649():1-9. PubMed ID: 36738577
[TBL] [Abstract][Full Text] [Related]
13. TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway.
Liu W; Chen G; Sun L; Zhang Y; Han J; Dai Y; He J; Shi S; Chen B
Front Oncol; 2019; 9():617. PubMed ID: 31338333
[No Abstract] [Full Text] [Related]
14. Fibronectin regulates anoikis resistance via cell aggregate formation.
Han HJ; Sung JY; Kim SH; Yun UJ; Kim H; Jang EJ; Yoo HE; Hong EK; Goh SH; Moon A; Lee JS; Ye SK; Shim J; Kim YN
Cancer Lett; 2021 Jun; 508():59-72. PubMed ID: 33771684
[TBL] [Abstract][Full Text] [Related]
15. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis.
Sharma U; Medina-Saenz K; Miller PC; Troness B; Spartz A; Sandoval-Leon A; Parke DN; Seagroves TN; Lippman ME; El-Ashry D
Breast Cancer Res Treat; 2021 Aug; 189(1):63-80. PubMed ID: 34216317
[TBL] [Abstract][Full Text] [Related]
16. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of autophagy protein LC3 and stemness (CD44+/CD24-/low) indicate poor prognosis in triple-negative breast cancer.
Chang SJ; Ou-Yang F; Tu HP; Lin CH; Huang SH; Kostoro J; Hou MF; Chai CY; Kwan AL
Hum Pathol; 2016 Feb; 48():48-55. PubMed ID: 26772398
[TBL] [Abstract][Full Text] [Related]
18. Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton.
Oliferenko S; Paiha K; Harder T; Gerke V; Schwärzler C; Schwarz H; Beug H; Günthert U; Huber LA
J Cell Biol; 1999 Aug; 146(4):843-54. PubMed ID: 10459018
[TBL] [Abstract][Full Text] [Related]
19. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.
D'Amato NC; Rogers TJ; Gordon MA; Greene LI; Cochrane DR; Spoelstra NS; Nemkov TG; D'Alessandro A; Hansen KC; Richer JK
Cancer Res; 2015 Nov; 75(21):4651-64. PubMed ID: 26363006
[TBL] [Abstract][Full Text] [Related]
20. Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ-secretase inhibitor drug responses.
Azzam DJ; Zhao D; Sun J; Minn AJ; Ranganathan P; Drews-Elger K; Han X; Picon-Ruiz M; Gilbert CA; Wander SA; Capobianco AJ; El-Ashry D; Slingerland JM
EMBO Mol Med; 2013 Oct; 5(10):1502-22. PubMed ID: 23982961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
